Close

Analyst Ratings for Atea Pharmaceuticals (AVIR) [Neutrals]

AVIR Rating Summary

  |   Expand Research on AVIR
Overall Rating: NEUTRAL   Rating Trend: Up   Avg. $ Target: N/A
Rating Score: 4 / 10   Percentile Rank: 39%
Date Firm Analyst Type Rating
(Past)
PT
(Past)
Start $
(End $)
% Chg. Details
11/18/2021 Leerink Partners Roanna Ruiz Downgrade Market Perform
(Outperform)
11.00
(20.00)
8.69
(3.69)
-57.54% Details